Nikfar S, Abdollahi M, Moretti ME, Magee LA, Koren G. Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis. Dig Dis Sci. 2002;47(7):1526–9.
Article
CAS
Google Scholar
Li CM, Zhernakova A, Engstrand L, Wijmenga C, Brusselaers N. Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy. Aliment Pharmacol Ther. 2020;51(4):410–20.
Article
Google Scholar
Boardman HF, Heeley G. The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors. Int J Clin Pharm. 2015;37(5):709–16.
Article
Google Scholar
Cohen J. Switching omeprazole in Sweden and the United States. Am J Ther. 2003;10(5):370–6.
Article
Google Scholar
Andersen AB, Erichsen R, Farkas DK, Mehnert F, Ehrenstein V, Sorensen HT. Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study. Aliment Pharmacol Ther. 2012;35(10):1190–8.
Article
CAS
Google Scholar
Goulet O. Potential role of the intestinal microbiota in programming health and disease. Nutr Rev. 2015;73(suppl_1):32–40.
Article
Google Scholar
Payne MS, Bayatibojakhi S. Exploring preterm birth as a polymicrobial disease: an overview of the uterine microbiome. Front Immunol. 2014;5:595.
Article
Google Scholar
Dunlop AL, Mulle JG, Ferranti EP, Edwards S, Dunn AB, Corwin EJ. Maternal microbiome and pregnancy outcomes that impact infant health: a review. Adv Neonatal Care. 2015;15(6):377–85.
Article
Google Scholar
Bayar E, Bennett PR, Chan D, Sykes L, MacIntyre DA. The pregnancy microbiome and preterm birth. Semin Immunopathol. 2020;42(4):487–99.
Article
Google Scholar
Fuhler GM. The immune system and microbiome in pregnancy. Best Pract Res Clin Gastroenterol. 2020;44–45:101671.
Article
Google Scholar
Imhann F, Bonder MJ, Vila AV, Fu J, Mujagic Z, Vork L, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65(5):740–8.
Article
CAS
Google Scholar
Brusselaers N, Pereira M, Alm J, Engstrand L, Lilja Engstrand H. Effect of proton pump inhibitors in infants with esophageal atresia on the gut microbiome: a pilot cohort Gut Pathogens. 2022:In press (acceptance pending)
Richter J. The management of heartburn in pregnancy. Aliment Pharmacol Ther. 2005;22(9):749–57.
Article
CAS
Google Scholar
Mahadevan U, Kane S. American Gastroenterological Association Institute Medical Position Statement on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006;131(1):278–82.
Article
Google Scholar
Omeprazole Pregnancy and Breastfeeding Warnings 2022 [cited 2022 October 2022]. Available from: https://www.drugs.com/pregnancy/omeprazole.html
Nielsen G, Sørensen H, Thulstrup A, Tage-Jensen U, Olesen C, Ekbom A. The safety of proton pump inhibitors in pregnancy. Aliment Pharmacol Ther. 1999;13(8):1085–9.
Article
CAS
Google Scholar
Diav-Citrin O, Arnon J, Shechtman S, Schaefer C, Van Tonningen M, Clementi M, et al. The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther. 2005;21(3):269–75.
Article
CAS
Google Scholar
Pasternak B, Hviid A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med. 2010;363(22):2114–23.
Article
CAS
Google Scholar
Matok I, Levy A, Wiznitzer A, Uziel E, Koren G, Gorodischer R. The safety of fetal exposure to proton-pump inhibitors during pregnancy. Dig Dis Sci. 2012;57(3):699–705.
Article
CAS
Google Scholar
Hastie R, Bergman L, Cluver CA, Wikman A, Hannan NJ, Walker SP, et al. Proton pump inhibitors and preeclampsia risk among 157 720 women: a Swedish population register–based cohort study. Hypertension. 2019;73(5):1097–103.
Article
CAS
Google Scholar
Fornes R, Simin J, M.N. N, Cruz G, Crisosto N, Van Der Schaaf M et al. Pregnancy, perinatal and childhood outcomes in women with and without Polycystic Ovary Syndrome and metformin during pregnancy: a nationwide population-based study. Reprod Biol Endocrinol. 2022;In press
Nguyen H, Fornes R, Kamau N, Danielsson H, Callens S, Fransson E et al. Antibiotic use during pregnancy and the risk of preterm birth: a population-based Swedish cohort study. J Antimicrob Chemother (JAC). 2022;In press
Källén BaK, Karin. The Swedish Medical Birth Register - a summary of content and quality. The Centre of Epdemiology - The National Board of Health and Welfare; 2003
The Swedish Medical Birth Registry - Statistics Sweden 2021 [Available from: https://www.socialstyrelsen.se/en/statistics-and-data/registers/register-information/the-swedish-medical-birth-register/.
Axelsson O. The Swedish medical birth register. Acta Obstet Gynecol Scand. 2003;82(6):491–2.
Article
Google Scholar
Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, et al. The new Swedish Prescribed Drug Register–opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–35.
Article
Google Scholar
Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
Article
Google Scholar
Socialstyrelsen. Kodningskvalitet i patientregistret - Ett nytt verktyg för att mäta kvalitet. 2013
Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659–67.
Article
Google Scholar
Fornes R, Simin J, Nguyen MH, Cruz G, Crisosto N, van der Schaaf M, et al. Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study. Reprod Biol Endocrinol: RB&E. 2022;20(1):30.
Article
CAS
Google Scholar
Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr. 1996;85(7):843–8.
Article
CAS
Google Scholar
Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:217047.
Article
Google Scholar
Hosmer DW, Lemeshow S, Sturdivant RX, Hosmer DW, Jr. Applied logistic regression. New York, UNITED STATES: Wiley, Incorporated; 2013
Agresti A. Categorical data analysis. Third;3rd; ed. Hoboken, N.J: Wiley-Interscience; 2013
Statistics Sweden. [January 2017]. Available from: http://www.socialstyrelsen.se/barnochfamilj/graviditet
Neter J, Kutner MH, Nachtsheim CJ, Wasserman W. Applied linear statistical models. 4th ed. Chicago, Ill: Irwin; 1996.
Google Scholar
Midi H, Sarkar SK, Rana S. Collinearity diagnostics of binary logistic regression model. J Interdisc Math. 2010;13(3):253–67.
Article
Google Scholar
Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13–22.
Article
Google Scholar
R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2019
Conway J, Eddelbuettel D, Nishiyama T, Prayaga SK, Tiffin N. RPostgreSQL: R Interface to the ‘PostgreSQL’ Database System. R Found Stat Comput. 2017. https://cran.r-project.org/web/packages/RPostgreSQL/RPostgreSQL.pdf.
Yee TW. Vector generalized linear and additive models: with an implementation in R. New York, USA: Springer; 2015.
Book
Google Scholar
Halekoh U, Højsgaard S, Yan J. The R package geepack for generalized estimating equations. J Stat Softw. 2006;15(2):1–11.
Article
Google Scholar
Bello NA, Huang Y, Syeda SK, Wright JD, D’Alton ME, Friedman AM. Receipt of proton-pump inhibitors during pregnancy and risk for preeclampsia. Am J Perinatol. 2021;38(14):1519–25.
Article
Google Scholar
Choi A, Noh Y, Park SH, Choe SA, Shin JY. Exploration of proton pump inhibitors use during pregnancy and preeclampsia. JAMA Netw Open. 2021;4(9):e2124339.
Article
Google Scholar
Phupong V, Hanprasertpong T. Interventions for heartburn in pregnancy. Cochrane Database Syst Rev. 2015;2015(9):Cd011379.
Google Scholar
Christopher L. The role of proton pump inhibitors in the treatment of heartburn during pregnancy. J Am Acad Nurse Pract. 2005;17(1):4–8.
Article
Google Scholar
Salvo EM, Ferko NC, Cash SB, Gonzalez A, Kahrilas PJ. Umbrella review of 42 systematic reviews with meta-analyses: the safety of proton pump inhibitors. Aliment Pharmacol Ther. 2021;54(2):129–43.
Article
CAS
Google Scholar
Imhann F, Vich Vila A, Bonder MJ, Lopez Manosalva AG, Koonen DPY, Fu J, et al. The influence of proton pump inhibitors and other commonly used medication on the gut microbiota. Gut Microbes. 2017;8(4):351–8.
Article
CAS
Google Scholar
Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. The Lancet. 2005;365(9461):785–99.
Article
Google Scholar
American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2004;27:S88.
Article
Google Scholar
Chatelain P. Children born with intrauterine growth retardation (IUGR) or small for gestational age (SGA): long term growth and metabolic consequences. Endocr Regul. 2000;34(1):33–6.
CAS
Google Scholar
Lund LK, Vik T, Lydersen S, Løhaugen GC, Skranes J, Brubakk A-M, et al. Mental health, quality of life and social relations in young adults born with low birth weight. Health Qual Life Outcomes. 2012;10(1):1–10.
Article
Google Scholar
Stubert J, Reister F, Hartmann S, Janni W. The risks associated with obesity in pregnancy. Deutsches Arzteblatt Int. 2018;115(16):276–83.
Google Scholar
Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ. 2017;356:j1.
Article
Google Scholar
Chen YH, Lin HC, Lou HY. Increased risk of low birthweight, infants small for gestational age, and preterm delivery for women with peptic ulcer. Am J Obstet Gynecol. 2010;202(2):164.e1-8.
Article
Google Scholar
Wilton LV, Pearce GL, Martin RM, Mackay FJ, Mann RD. The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol. 1998;105(8):882–9.
Article
CAS
Google Scholar
Hastie R, Bergman L, Cluver CA, Wikman A, Hannan NJ, Walker SP, et al. Proton pump inhibitors and preeclampsia risk among 157 720 women. Hypertension. 2019;73(5):1097–103.
Article
CAS
Google Scholar
Ruigomez A, Garcia Rodriguez LA, Cattaruzzi C, Troncon MG, Agostinis L, Wallander MA, et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol. 1999;150(5):476–81.
Article
CAS
Google Scholar
Halfdanarson OO, Pottegard A, Bjornsson ES, Lund SH, Ogmundsdottir MH, Steingrimsson E, et al. Proton-pump inhibitors among adults: a nationwide drug-utilization study. Therap Adv Gastroenterol. 2018;11:1756284818777943.
Article
Google Scholar
Liu Y, Zhu X, Li R, Zhang J, Zhang F. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study. BMJ Open. 2020;10(11):e040473.
Article
Google Scholar
Pottegard A, Broe A, Hallas J, de Muckadell OB, Lassen AT, Lodrup AB. Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study. Ther Adv Gastroenterol. 2016;9(5):671–8.
Article
Google Scholar
Rotman SR, Bishop TF. Proton pump inhibitor use in the U.S. ambulatory setting, 2002-2009. PloS one. 2013;8(2):e56060.
Article
CAS
Google Scholar
Tosetti C, Nanni I. Use of proton pump inhibitors in general practice. World J Gastrointest Pharmacol Ther. 2017;8(3):180–5.
Article
Google Scholar
Cohen J. Switching omeprazole in Sweden and the United States. Am J Ther. 2003;10(5):370–6.
Article
Google Scholar
Fertility Statistics - Eurostat statistics explained [cited 2022. Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Fertility_statistics#The_birth_rate_in_the_EU_decreased_at_a_slower_pace_between_2000_and_2020_than_previously
Boghossian TA, Rashid FJ, Thompson W, Welch V, Moayyedi P, Rojas-Fernandez C, et al. Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database Syst Rev. 2017;3:CD011969.
Google Scholar
Kim J, Blackett JW, Jodorkovsky D. Strategies for effective discontinuation of proton pump inhibitors. Curr Gastroenterol Rep. 2018;20(6):27.
Article
Google Scholar
Cluver CA, Hannan NJ, van Papendorp E, Hiscock R, Beard S, Mol BW, et al. Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial. Am J Obstet Gynecol. 2018;219(4):388 e1-e17.
Article
Google Scholar
Fadl HE, Simmons D. Trends in diabetes in pregnancy in Sweden 1998–2012. BMJ Open Diabetes Res Care. 2016;4(1):e000221.
Article
Google Scholar
Berkowitz GS, Blackmore-Prince C, Lapinski RH, Savitz DA. Risk factors for preterm birth subtypes. Epidemiology. 1998:9(3):279–85.